Prevalence of mental, neurological, and substance use disorders in China and India: a systematic analysis

The Lancet Psychiatry

Volumn 3, Issue 9, 2016, Pages 832-841

  Baxter, Amanda J ^a,b,c   Charlson, Fiona J ^a,b,c   Cheng, Hui G ^d   Shidhaye, Rahul ^e,f   Ferrari, Alize J ^a,b,c   Whiteford, Harvey A ^a,b,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Queensland Centre for Mental Health Research   (Australia)

^c UNIVERSITY OF WASHINGTON   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^f MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLISM; ANXIETY DISORDER; ARTICLE; AUTISM; CHINA; DSM-IV; DYSTHYMIA; EPILEPSY; FUNDING; HUMAN; INDIA; MAJOR DEPRESSION; MENTAL DISEASE; NEUROLOGIC DISEASE; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBSTANCE ABUSE; SYSTEMATIC REVIEW; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; SUBSTANCE-RELATED DISORDERS;

CHINA; HUMANS; INDIA; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; PREVALENCE; SUBSTANCE-RELATED DISORDERS;

EID: 84983262223     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(16)30139-0     Document Type: Article

References (43)

1. 1 The World Bank. Data, indicators. http://data.worldbank.org/indicator/NY.GDP.MKTP.KD.ZG, 2016 (accessed March 21, 2016).
2. 2 Institute for Health Metrics and Evaluation (IHME). Viz Hub: Life Expectancy and Probability of Death. http://vizhub.healthdata.org/le/, 2014 (accessed March 16, 2016).
3. 3 Murray, CJL, Barber, RM, Foreman, KJ, et al., for the GBD 2013 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet 386 (2015), 2145–2191.
4. 4 Charlson, FJ, Baxter, AJ, Cheng, HG, Shidhaye, R, Whiteford, HA, The burden of mental, neurological, and substance use disorders in China and India: a systematic analysis of community representative epidemiological studies. Lancet, 2016 published online May 18, 2016. http://dx.doi.org/10.1016/S0140-6736(16)30590-6.
5. 5 Raban, MZ, Dandona, R, Dandona, L, Availability of data for monitoring noncommunicable disease risk factors in India. Bull World Health Organ 90 (2012), 20–29.
6. 6 Zhou, M, Wang, H, Zhu, J, et al. Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 387 (2016), 251–272.
7. 7 Yang, G, Wang, Y, Zeng, Y, et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 381 (2013), 1987–2015.
8. 8 Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 743–800.
9. 9 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), 4th text revision edn., 2000, American Psychiatric Association, Washington, DC.
10. 10 Chen, YF, Chinese Classification of Mental Disorders (CCMD-3): Towards Integration in International Classification. Psychopathology 35 (2002), 171–175.
11. 11 WHO. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research, 1993, World Health Organisation, Geneva.
12. 12 Bruckner, TA, Scheffler, RM, Shen, G, et al. The mental health workforce gap in low-and middle-income countries: a needs-based approach. Bull World Health Organ 89 (2011), 184–194.
13. 13 Patel, V, Thornicroft, G, Packages of care for mental, neurological, and substance use disorders in low-and middle-income countries: PLoS Medicine Series. PLoS Med, 6, 2009, e1000160.
14. 14 Ferrari, AJ, Somerville, AJ, Baxter, AJ, et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med 43 (2013), 471–481.
15. 15 Ferrari, AJ, Baxter, AJ, Whiteford, HA, A systematic review of the global distribution and availability of prevalence data for bipolar disorder. J Affect Disord 134 (2010), 1–13.
16. 16 Baxter, AJ, Scott, KM, Vos, T, Whiteford, HA, Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med 43 (2013), 897–910.
17. 17 Charlson, FJ, Ferrari, AJ, Flaxman, AD, Whiteford, HA, The epidemiological modelling of dysthymia: application for the Global Burden of Disease Study 2010. J Affect Disord 151 (2013), 111–120.
18. 18 Erskine, HE, Ferrari, AJ, Nelson, P, et al. Research Review: Epidemiological modelling of attention-deficit/hyperactivity disorder and conduct disorder for the Global Burden of Disease Study 2010. J Child Psychol Psychiatry 54 (2013), 1263–1274.
19. 19 Baxter, AJ, Brugha, TS, Erskine, HE, Scheurer, RW, Vos, T, Scott, JG, The epidemiology and global burden of autism spectrum disorders. Psychol Med 45 (2015), 601–613.
20. 20 Degenhardt, L, Bucello, C, Calabria, B, et al. What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug Alcohol Depend 117 (2011), 85–101.
21. 21 Moffitt, TE, Caspi, A, Taylor, A, et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med 40 (2010), 899–909.
22. 22 Baxter, AJ, Patton, G, Degenhardt, L, Scott, KM, Whiteford, HA, Global epidemiology of mental disorders: what are we missing?. PLoS One, 8, 2013, e65514.
23. 23 Erskine, HE, Baxter, AJ, Patton, G, et al. The global coverage of prevalence data for mental disorders in children and adolescents. Epidemiol Psychiatr Sci, 2016 published online Jan 20. http://dx.doi.org/10.1017/S2045796015001158.
24. 24 Flaxman, A, Murray, C, Vos, T, (eds.) Integrated meta-regression framework for descriptive epidemiology, 2015, University of Washington Press, Seattle, WA.
25. 25 GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385 (2015), 117–171.
26. 26 Li, N, Chen, G, Song, X, Du, W, Zheng, X, Prevalence of autism-caused disability among Chinese children: a national population-based survey. Epilepsy Behav 22 (2011), 786–789.
27. 27 Hao, W, Su, Z, Liu, B, et al. Drinking and drinking patterns and health status in the general population of five areas of China. Alcohol Alcohol 39 (2004), 43–52.
28. 28 Phillips, MR, Zhang, J, Shi, Q, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001–05: an epidemiological survey. Lancet 373 (2009), 2041–2053.
29. 29 Hao Tang, MD, Chen, L, Shao, S, Epidemiological survey of adult epilepsy in five eastern China provinces. J Clin Neurol 3 (1991), 139–142.
30. 30 WHO. Global Status Report on Alcohol, 2004, 2008, World Health Organization, Geneva.
31. 31 WHO. China WHO Multi-country Survey Study on Health and Health System Responsiveness, 2001, Institute of Social Medicine and Health Policy, Shandong University, Shandong University School of Medicine, World Health Organization, Geneva.
32. 32 Wang, W, Wu, J, Wang, D, et al. Epidemiological survey on epilepsy among rural populations in five provinces in China. Zhonghua Yi Xue Za Zhi 82 (2002), 449–452 (in Chinese).
33. 33 Chan, KY, Zhao, FF, Meng, S, et al. Prevalence in schizophrenia in China between 1990 and 2010. J Glob Health, 5, 2015, 8.
34. 34 Long, J, Huang, G, Liang, W, et al. The prevalence of schizophrenia in mainland China: evidence from epidemiological surveys. Acta Psychiatr Scand 130 (2014), 244–256.
35. 35 Ganguli, HC, Epidemiological findings on prevalence of mental disorders in India. Indian J Psychiatry 42 (2000), 14–20.
36. 36 Reddy, VM, Chandrashekar, CR, Prevalence of mental and behavioural disorders in India: a meta-analysis. Indian J Psychiatry 40:2 (1998), 149–157.
37. 37 World Health Organization. Country profiles. http://www.who.int/countries/en/, 2016 (accessed March 21, 2016).
38. 38 Cheng, H, Shidhaye, R, Charlson, F, et al. Social correlates of mental, neurological, and substance use disorders in China and India: a review. Lancet Psychiatry, 2016 published online Aug 12. http://dx.doi.org/10.1016/S2215-0366(16)30166-3.
39. 39 Cheng, HG, Deng, F, Xiong, W, Phillips, MR, Prevalence of alcohol use disorders in mainland China: a systematic review. Addiction 110 (2015), 761–774.
40. 40 WHO. Global burden of mental disorders and the need for a comprehensive, coordinated response from health and social sectors at the country level: Report by the Secretariat, 2011, World Health Organization Executive Board, Geneva.
41. 41 Evans-Lacko, S, Ribeiro, W, Brietzke, E, et al. Lean economies and innovation in mental health systems. Lancet 387 (2016), 1356–1357.
42. 42 Giovino, GA, Mirza, SA, Samet, JM, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 380 (2012), 668–679.
43. 43 Whiteford, H, Degenhardt, L, Rehm, J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 382 (2013), 1575–1586.